SG11201507264YA - Thermostable blunt-end ligase and methods of use - Google Patents
Thermostable blunt-end ligase and methods of useInfo
- Publication number
- SG11201507264YA SG11201507264YA SG11201507264YA SG11201507264YA SG11201507264YA SG 11201507264Y A SG11201507264Y A SG 11201507264YA SG 11201507264Y A SG11201507264Y A SG 11201507264YA SG 11201507264Y A SG11201507264Y A SG 11201507264YA SG 11201507264Y A SG11201507264Y A SG 11201507264YA
- Authority
- SG
- Singapore
- Prior art keywords
- methods
- thermostable blunt
- end ligase
- ligase
- thermostable
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/93—Ligases (6)
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
- C07K14/4702—Regulators; Modulating activity
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P19/00—Preparation of compounds containing saccharide radicals
- C12P19/26—Preparation of nitrogen-containing carbohydrates
- C12P19/28—N-glycosides
- C12P19/30—Nucleotides
- C12P19/34—Polynucleotides, e.g. nucleic acids, oligoribonucleotides
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6844—Nucleic acid amplification reactions
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y605/00—Ligases forming phosphoric ester bonds (6.5)
- C12Y605/01—Ligases forming phosphoric ester bonds (6.5) forming phosphoric ester bonds (6.5.1)
- C12Y605/01001—DNA ligase (ATP) (6.5.1.1)
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/20—Fusion polypeptide containing a tag with affinity for a non-protein ligand
- C07K2319/21—Fusion polypeptide containing a tag with affinity for a non-protein ligand containing a His-tag
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/80—Fusion polypeptide containing a DNA binding domain, e.g. Lacl or Tet-repressor
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Zoology (AREA)
- Engineering & Computer Science (AREA)
- Wood Science & Technology (AREA)
- Genetics & Genomics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- General Engineering & Computer Science (AREA)
- Microbiology (AREA)
- Biotechnology (AREA)
- Medicinal Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biomedical Technology (AREA)
- General Chemical & Material Sciences (AREA)
- Biophysics (AREA)
- Toxicology (AREA)
- Gastroenterology & Hepatology (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Immunology (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201361802124P | 2013-03-15 | 2013-03-15 | |
PCT/US2014/030003 WO2014145269A1 (en) | 2013-03-15 | 2014-03-15 | Thermostable blunt-end ligase and methods of use |
Publications (1)
Publication Number | Publication Date |
---|---|
SG11201507264YA true SG11201507264YA (en) | 2015-10-29 |
Family
ID=51528783
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SG11201507264YA SG11201507264YA (en) | 2013-03-15 | 2014-03-15 | Thermostable blunt-end ligase and methods of use |
Country Status (9)
Country | Link |
---|---|
US (4) | US9273301B2 (en) |
EP (2) | EP2970922B1 (en) |
AU (1) | AU2014233213A1 (en) |
CA (1) | CA2903873C (en) |
ES (2) | ES2904847T3 (en) |
IL (1) | IL241073B (en) |
PL (1) | PL2970922T3 (en) |
SG (1) | SG11201507264YA (en) |
WO (1) | WO2014145269A1 (en) |
Families Citing this family (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ES2904847T3 (en) | 2013-03-15 | 2022-04-06 | Labrador Diagnostics Llc | Thermostable blunt-end ligase and methods of use |
JP2016521120A (en) | 2013-03-15 | 2016-07-21 | セラノス, インコーポレイテッド | Nucleic acid amplification |
CA2921226A1 (en) | 2013-09-06 | 2015-03-12 | Theranos, Inc. | Devices, systems, methods and kits for receiving a swab |
EP3277837A1 (en) * | 2015-03-31 | 2018-02-07 | Qiagen GmbH | Efficiency improving ligation methods |
KR20200003903A (en) * | 2017-05-08 | 2020-01-10 | 코덱시스, 인코포레이티드 | Engineered Ligase Variants |
CN108220255B (en) * | 2017-09-24 | 2021-03-16 | 天津强微特生物科技有限公司 | Thermophilic archaea high-activity DNA ligase mutant |
US10837009B1 (en) | 2017-12-22 | 2020-11-17 | New England Biolabs, Inc. | DNA ligase variants |
WO2020124319A1 (en) * | 2018-12-17 | 2020-06-25 | 深圳华大生命科学研究院 | Fusion protein and application thereof |
Family Cites Families (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4683202A (en) | 1985-03-28 | 1987-07-28 | Cetus Corporation | Process for amplifying nucleic acid sequences |
US5700672A (en) * | 1992-07-23 | 1997-12-23 | Stratagene | Purified thermostable pyrococcus furiousus DNA ligase |
ES2393056T3 (en) | 1998-11-09 | 2012-12-18 | Eiken Kagaku Kabushiki Kaisha | Nucleic Acid Synthesis Procedure |
WO2005047547A1 (en) | 2003-11-04 | 2005-05-26 | Applera Corporation | Concatameric ligation products: compositions, methods and kits for same |
JP4486009B2 (en) | 2005-08-10 | 2010-06-23 | 株式会社日立製作所 | DNA ligase mutant |
DK2205968T3 (en) | 2007-10-02 | 2014-02-17 | Theranos Inc | Modular POC (point of care) Devices and uses thereof |
CN102597006A (en) * | 2009-09-16 | 2012-07-18 | 梅西大学 | Fusion polypeptides and uses thereof |
US8380541B1 (en) | 2011-09-25 | 2013-02-19 | Theranos, Inc. | Systems and methods for collecting and transmitting assay results |
ES2904847T3 (en) | 2013-03-15 | 2022-04-06 | Labrador Diagnostics Llc | Thermostable blunt-end ligase and methods of use |
US9416387B2 (en) * | 2013-03-15 | 2016-08-16 | Theranos, Inc. | Nucleic acid amplification |
BR112016011692A2 (en) * | 2013-11-22 | 2017-09-26 | Theranos Inc | nucleic acid amplification |
-
2014
- 2014-03-15 ES ES17206830T patent/ES2904847T3/en active Active
- 2014-03-15 ES ES14762285.6T patent/ES2661662T3/en active Active
- 2014-03-15 EP EP14762285.6A patent/EP2970922B1/en not_active Not-in-force
- 2014-03-15 CA CA2903873A patent/CA2903873C/en active Active
- 2014-03-15 AU AU2014233213A patent/AU2014233213A1/en not_active Abandoned
- 2014-03-15 US US14/214,834 patent/US9273301B2/en active Active
- 2014-03-15 SG SG11201507264YA patent/SG11201507264YA/en unknown
- 2014-03-15 WO PCT/US2014/030003 patent/WO2014145269A1/en active Application Filing
- 2014-03-15 EP EP17206830.6A patent/EP3360958B1/en not_active Not-in-force
- 2014-03-15 PL PL14762285T patent/PL2970922T3/en unknown
-
2015
- 2015-09-02 IL IL241073A patent/IL241073B/en active IP Right Grant
- 2015-09-04 US US14/846,285 patent/US20160186164A1/en not_active Abandoned
-
2016
- 2016-01-20 US US15/002,013 patent/US9719081B2/en active Active
-
2017
- 2017-02-24 US US15/442,110 patent/US20170298338A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
CA2903873C (en) | 2023-09-05 |
US20160186164A1 (en) | 2016-06-30 |
EP2970922A4 (en) | 2016-10-12 |
US9719081B2 (en) | 2017-08-01 |
ES2904847T3 (en) | 2022-04-06 |
CA2903873A1 (en) | 2014-09-18 |
EP3360958B1 (en) | 2021-12-22 |
US20170298338A1 (en) | 2017-10-19 |
US9273301B2 (en) | 2016-03-01 |
AU2014233213A1 (en) | 2015-09-17 |
US20170015989A1 (en) | 2017-01-19 |
IL241073B (en) | 2018-08-30 |
ES2661662T3 (en) | 2018-04-03 |
EP2970922A1 (en) | 2016-01-20 |
IL241073A0 (en) | 2015-11-30 |
EP2970922B1 (en) | 2017-12-13 |
WO2014145269A1 (en) | 2014-09-18 |
US20140273102A1 (en) | 2014-09-18 |
PL2970922T3 (en) | 2018-06-29 |
EP3360958A1 (en) | 2018-08-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HUS2200048I1 (en) | Fcrn antagonists and methods of use | |
HRP20170840T1 (en) | Substituted xanthines and methods of use thereof | |
HK1217428A1 (en) | Substituted benzoxazoles and methods of use thereof | |
HK1223913A1 (en) | Substituted benzamides and methods of use thereof | |
SG11201600028YA (en) | Substituted aminopyrimidine compounds and methods of use | |
IL241073A0 (en) | Thermostable blunt-end ligase and methods of use | |
IL244268A0 (en) | Heterocyclic compounds and methods of use | |
PL3019477T3 (en) | Heterocyclic compounds and methods of their use | |
IL245272A0 (en) | Pif-transfected cells and methods of use | |
SG11201507389RA (en) | Integration of hydro-dechlorination and hydro-regeneration | |
GB201310349D0 (en) | Composition and method of use thereof | |
GB201301928D0 (en) | Composition and method of use thereof |